---
"title": "DiSC Health: What Black Americans Need to Know About Clinical Trials for Lung Cancer"
"description": "Discover essential information for Black Americans about lung cancer clinical trials. Learn about participation, benefits, and ways to overcome barriers to access better treatment options."
"date": "2026-11-21"
"authors":
  -
    "name": "Blackdoctors.org"
"url": "https://thenarrativematters.com/disc-health-what-black-americans-need-to-know-about-clinical-trials-for-lung-cancer/"
"categories":
  - "DISC Health"
  - "Health"
"tags":
  - "African American Health"
  - "Black Americans"
  - "Cancer Research"
  - "clinical trials"
  - "health disparities"
  - "Health education"
  - "Lung Cancer"
  - "Oncology"
  - "Patient Advocacy"
---

# DiSC Health: What Black Americans Need to Know About Clinical Trials for Lung Cancer

![Image Fcb3bf](https://thenarrativematters.com/wp-content/uploads/sites/48/2026/11/image_fcb3bf.png)
_A chemo patient checking out his phone, during treatment Image by Blackdoctor_

Lung cancer, or bronchogenic carcinoma, is the collective term for cancers that start in the lungs — usually in the airways (bronchi or bronchioles) or small air sacs (alveoli). Lung cancer is known for its aggressive nature and high mortality rate. [Eric Singhi, M.D.](https://faculty.mdanderson.org/profiles/eric_singhi.html), Assistant Professor in the Department of Thoracic, Head, and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center, says more people die from lung cancer than from breast, prostate, and colon cancers combined.

“This type of cancer can metastasize early and widely, leading to frequent late-stage diagnosis,” Dr. Singhi explains. “There are different types of lung cancer, which we generally categorize into non-small cell lung cancer (NSCLC), which represents 85 percent of all cases of lung cancer, and small cell lung cancer (SCLC). NSCLC tends to spread more slowly than SCLC. However, both NSCLC and SCLC can be aggressive, with SCLC often being particularly fast-growing and prone to early spread/metastasis.“

Despite medical advancements in treatments beyond conventional chemotherapy, such as targeted therapies and immunotherapy, Dr. Singhi says many lung cancers eventually become resistant to treatment, requiring ongoing research into new solutions.

## **What Are Clinical Trials?**

Clinical trials are research studies that evaluate the safety and efficacy of new treatments, including procedures, drugs, and therapies. They may also explore combinations of treatments and medications that are already available. These trials progress through several main stages: Phase I, II, and III, with some trials combining phases or including additional stages such as Phase 0 and Phase IV.

Phase I trials are the initial stage, where a new treatment is tested on a small group of 15 to 50 people. The primary goals of Phase I trials are to evaluate the treatment’s safety, determine the best method of administration (such as oral or intravenous), and identify any side effects. This phase can take several years to complete.

In Phase II, the focus shifts to assessing the treatment’s effectiveness against lung cancer. This phase involves a larger group of over 100 people and continues to gather information on possible side effects to further examine the treatment’s safety.

Phase III trials expand the treatment’s testing to even larger groups. The objectives in this phase are to confirm the treatment’s efficacy, monitor side effects, compare it to commonly used treatments, and collect comprehensive information to ensure its safe use. After completing Phase III, the [U.S. Food and Drug Administration (FDA)](https://www.fda.gov/about-fda/oncology-center-excellence/patient-friendly-language-cancer-clinical-trials) reviews the trial results to determine whether the treatment is safe and effective enough for public use. Based on this review, the FDA decides whether to approve the treatment for general use.

Phase IV trials, also known as “post-marketing surveillance,” are conducted after the treatment has been licensed and approved by the FDA. These trials gather additional information on the treatment’s effects in various populations and monitor any long-term side effects. Phase IV trials may also study the treatment’s effectiveness against different types of cancer.

Clinical trials are a key part of developing new treatments, as they provide the data needed for regulatory approval and public access to potentially life-saving therapies. They offer some patients the opportunity to access experimental treatments, contributing to medical knowledge and potentially saving many lives.

## **Benefits of Participating in a Lung Cancer Clinical Trial**

Dr. Singhi says, “There are many benefits to enrollment in clinical trials, such as potentially more effective or safer treatments, active involvement in health care decisions, and a direct contribution to advanced understanding and potential improvements in disease management.” Potential risks include unknown side effects, ineffective treatment, and time and financial losses during the trial.

However, these concerns are outlined before a patient gives informed consent. “Barriers to clinical trial enrollment include lack of awareness among healthcare clinicians and patients about available trials, eligibility criteria that can limit participation, time and travel commitments, the financial burden associated with travel, language and cultural challenges, and patients’ distrust of researchers and clinicians,” Dr. Singhi explains.

## **Types of Clinical Trials for Lung Cancer**

Lung cancer clinical trials frequently focus on cutting-edge approaches. For example, targeted therapy trials usually investigate new drugs that interfere with specific molecules responsible for tumor growth. Immunotherapy trials aim to enhance the body’s immune response to lung cancer cells. These trials often explore treatments like checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapy, all designed to boost the immune system’s ability to fight cancer. Other trials also investigate new combinations of chemotherapy drugs.

Ongoing lung cancer clinical trials are being conducted at leading institutions, including the National Cancer Institute, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. You can learn more about clinical trials offered in the United States by visiting the [NIH National Cancer Institute website](https://www.cancer.gov/research/participate/clinical-trials-search).

## **Finding a Lung Cancer Clinical Trial**

Finding a suitable clinical trial can be challenging. The first step is to talk to your doctor or health care provider. They can help you understand your options and recommend specific trials. They may also help submit your name for approval, especially for invitation-only trials. Several resources can help patients and their families find clinical trials. Before you begin searching, gather your medical information so you can quickly check eligibility.

Online databases offer comprehensive listings of clinical trials, including eligibility details, locations, and contact information. [ClinicalTrials.gov](https://clinicaltrials.gov/) is the most extensive database, allowing you to search by tumor type and other criteria. The [National Cancer Institute](https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci) provides resources and support for finding clinical trials. Larger cancer centers, including the [Mayo Clinic Lung Cancer Program](https://www.mayoclinic.org/departments-centers/lung-cancer-program/sections/clinical-trials/rsc-20474883), [Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/cancer-care/types/lung/clinical-trials), and [Stanford Medicine](https://med.stanford.edu/cancer/clinical-trials.html), also maintain databases of lung cancer clinical trials offered at their institutions. Also, search [BlackDoctor’s vetted list of clinical trials](https://blackdoctor.com/clinical-trials-resource-center/) aimed at Black Americans.

[READ MORE](https://blackdoctor.com/what-black-americans-need-to-know-clinical-trials-for-lung-cancer/)

Courtesy of our partners at EIN PRESSWIRE, and we at The Narrative Matters are happy to know that Blackdoctor is back with a fresh new website. A site we have been sharing for over three years!